Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

ARA-290 (Cibinetide) — The Complete History

The Legacy A Peptide That Teaches Healing Today, ARA 290 (also called cibinetide) continues in clinical development. Key Moment ARA 290 may become one of the first drugs that genuinely regenerates damaged nerves. Today, ARA 290 (also called cibinetide) continu

By Recovery & Performance Peptides Editorial Team

The Legacy

A Peptide That Teaches Healing

Today, ARA 290 (also called cibinetide) continues in clinical development.

Key Moment

ARA 290 may become one of the first drugs that genuinely regenerates damaged nerves.

Today, ARA 290 (also called cibinetide) continues in clinical development. Araim Pharmaceuticals, the company developing it, has conducted trials in diabetic neuropathy and chronic kidney disease. The peptide represents a new approach to medicine: instead of blocking a disease process, it activates the body's own repair systems. Scientists believe ARA 290 works by telling damaged tissues to stop dying and start healing. The journey from EPO's mysterious side effects to a purpose-built healing peptide shows how careful observation can lead to entirely new categories of medicine. ARA 290 may become one of the first drugs that genuinely regenerates damaged nerves.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

03

Evidence cooldown

Research context and source excerpts for a slower second read.

POTENTIAL BENEFITS

Primary Benefits

ARA-290 actively regrows small nerve fibers that die from diabetes, neuropathy, or injury. Studies show real improvements in nerve density on corneal imaging. Reduces neuropathic pain through both nerve repair and anti-inflammatory pathways. Users report decreased shooting pain and burning sensations. Protects pancreatic cells, organs, and tissues from stress damage. Works especially well in diabetes where tissues face constant oxidative harm.
05

Product & matchup locker

Linked catalog and comparison files.

Comparison

ARA-290 vs Erythropoietin and Related Tissue-Protective Peptides

Because ARA-290 is defined largely by what it is not (erythropoietic), a side-by-side comparison with its parent molecule and with the broader helix-B peptide family clarifies whe…

Continue reading

Related articles